Antiplaque Claims Spectrum Outlined By WhiteHill
This article was originally published in The Rose Sheet
Executive Summary
Products carrying antiplaque-only claims should be permitted in the OTC antigingivitis/antiplaque monograph, WhiteHill Oral Technologies states in Nov. 24 comments to FDA
You may also be interested in...
Antiplaque Essential Oil In Vitro Plus In Vivo Test Requirement Urged By Pfizer
The antigingivitis/antiplaque monograph should require that products containing a fixed combination of the essential oils menthol, thymol, methyl salicylate and eucalyptol be tested with both in vitro and in vivo test methods, Pfizer Consumer Healthcare maintains
Antigingivitis/Antiplaque Combination With Other Actives Excluded In ANPR
FDA's advance notice of proposed rulemaking on OTC antigingivitis/antiplaque products excludes the combination of antigingivitis/antiplaque ingredients with other oral health care ingredients. The 1notice was published in the May 29 Federal Register
FDA Should Allow "Qualified" Plaque-Only Cosmetics Claims, WhiteHill Says
Plaque-only claims "qualified with cosmetic benefits" should be included in the eventual OTC monograph for antiplaque/antigingivitis drugs, WhiteHill Oral Technologies urges in recent comments to FDA. Examples of "qualified plaque claims" include "Reduces plaque for a cleaner mouth"; "Reduces plaque for cleaner teeth"; or "Reduces plaque associated with bad breath," WhiteHill says.